Not applicableNo Longer AvailableNCT04724421
What this trial is testing
Expanded Access Protocol for Adults and Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment Options
Who this might be right for
Sickle Cell Disease
Pfizer